Alternatives to Star Therapeutics
Star Therapeutics is a Biotechnology tool: a biotechnology company focused on the discovery and development of life-changing therapies for diseases with significant unmet need. Here are the 54 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Star Therapeutics
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
BioNTechNot ratedGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Mammoth BiosciencesNot ratedBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
VizgenNot ratedSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Supernus PharmaceuticalsNot ratedBiopharmaceutical company developing and commercializing CNS disease treatments.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
Network BioNot ratedLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Showing the next 20 closest matches. See the rest on the Star Therapeutics profile.
